Search Results - M. M. Petrova

Refine Results
  1. 1

    Attitude to illness in pancreatic diabetes patients by M. M. Petrova, T. A. Rachko

    Published 2006-12-01

    The study of the psychological status of 224 type 1 and 2 pancreatic diabetes (PD) patients has revealed the dominant types of the attitude to illness. In type 1 PD patients, regardless of the sex, the dominant type was ergopatic, which may lead tounsatisfactory results of treatment. However, the an...

    Full description

    Get full text
    Article
  2. 2

    COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION by O. P. Bobrova, M. M. Petrova

    Published 2015-12-01

    Aim. To study the pharmacokinetic, pharmacodynamic and pharmacoeconomic parameters of the original and generic enalaprils in the treatment of the elderly patients with hypertension (HT). Material and Methods. Patients (n=40) 75–90 years with HT were included in the open randomized comparative study....

    Full description

    Get full text
    Article
  3. 3

    Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine by O. V. Zimnitskaya, M. M. Petrova

    Published 2016-11-01

    Aim. To study the effect of olmesartan/lercanidipine combination and zofenopril/lercanidipine combination on the level of soluble platelet-endothelial cell adhesion molecule of the first type (sPECAM-1) in plasma in patients with essential hypertension (HT) stage II-III.Material and methods. We exam...

    Full description

    Get full text
    Article
  4. 4

    PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION by D. S. Kaskaeva, M. M. Petrova, O. V. Zimnitskaya

    Published 2017-03-01

    Objective. Pharmacoeconomic analysis of the use of combinations of antihypertensive drugs were olmesartan/lercanidipine and zofenopril/lercanidipine in patients with essential hypertension II-III stage.Materials and methods. The authors performed prospective randomized uncontrolled study. Were exami...

    Full description

    Get full text
    Article
  5. 5

    Analysis of safety of bioactive concentrate of small sea fish therapy in comorbid patients with osteoarthritis by O. V. Zimnitskaya, M. M. Petrova, P. A. Shesternya

    Published 2021-06-01

    The article discusses the safety issues of a bioactive concentrate of small sea fish (BCSSF, Alflutop®) in the treatment of osteoarthritis (OA). The data of original studies, which were published during 2001–2021 years, from eLIBRARY, PubMed and Web of Science databases were analyzed. The selection...

    Full description

    Get full text
    Article
  6. 6

    ASSOCIATION BETWEEN ANXIETY-DEPRESSIVE SPECTRUM DISORDERS AND JOINT DISEASE IN WOMEN by A. O. Vasilyeva, P. A. Shesternya, M. M. Petrova

    Published 2018-01-01

    The frequency of anxiety-depressive spectrum disorders (ADSDs) in patients with rheumatic diseases (RDs) is much higher than that in the general population. ADSDs are known to be associated with pain intensity, disease activity, and functional limitations. However, the majority of available papers a...

    Full description

    Get full text
    Article
  7. 7

    Biomarkers of vascular cognitive impairment by O. V. Zimnitskaya, E. Yu. Mozheyko, M. M. Petrova

    Published 2021-05-01

    There is currently no approved list of vascular cognitive impairment biomarkers. The main problem for the practitioner in identifying cognitive impairment in patients is the differential diagnosis of Alzheimer's disease, vascular cognitive impairment, and other diseases, which are much less com...

    Full description

    Get full text
    Article
  8. 8

    Cognitive dysfunction in arterial hypertension patients by M. M. Petrova, N. A. Shnayder, O. V. Eremina

    Published 2008-04-01

    Aim. To study the severity of cognitive dysfunction (CD) in patients with arterial hypertension (AH).Material and methods. The study included 147 patients: 97 (66%) women and 50 (34%) men with AH of various stages. Patients age varied from 40 to 75 years (mean age 63,2+10,8 years). The participants...

    Full description

    Get full text
    Article
  9. 9

    EXTRACORPOREAL HAEMOCORRECTION AND ITS IMPACT ON FREE-RADICAL OXIDATION AND ANTIOXIDANT DEFENSE IN ABDOMINAL SEPSIS by V. S. Petrov, M. M. Petrova, S. V. Sviridov, D. V. Surmenev

    Published 2018-02-01

    Goal: to investigate the impact of extracorporeal haemocorrection on free-radical oxidation and antioxidant defense in those with abdominal sepsis. Subjects and methods. 46 patients were examined. All patients were divided into two groups. Patients from the main group (n = 23) had metabolic support...

    Full description

    Get full text
    Article
  10. 10

    THE ROLE OF INTERLEUKIN 1β GENE POLYMORPHISM IN DEVELOPMENT OF PREDOMINANTY SENSORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY by T. E. Popova, N. A. Shnayder, M. M. Petrova, A. A. Tappakhov

    Published 2019-01-01

    The aim of the present study was a search for associations between the polymorphic allelic variants 3954 C>T (rs1143644) and -511C>T (rs16944) of IL1B gene in the patients with sensory predominant chronic inflammatory demyelinating polyneuropathies (SP-CIDP) from Krasnoyarsk Region and...

    Full description

    Get full text
    Article
  11. 11

    Orthostatic Hypotension: Definition, Pathophysiology, Classification, Prognostic Aspects, Diagnostics and Treatment by O. D. Ostroumova, M. S. Cherniaeva, M. M. Petrova, O. V. Golovina

    Published 2018-11-01

    The urgency of the problem of orthostatic hypotension (OH) has increased in recent years. It was due to the high prevalence and its adverse effect on the prognosis and  quality of life of patients, especially the elderly and  oldest old. The purpose of this review was to summarize the contemporary d...

    Full description

    Get full text
    Article
  12. 12

    AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE by N. Yu. Shimohina, M. M. Petrova, A. A. Savchenko, M. S. Chernyaeva

    Published 2017-03-01

    According to the World Health Organization, anxiety and depressive disorders will be the second  leading cause of disability by 2020. The review is devoted to the modern concepts of the pathophysiology of depression in patients with ischemic heart  disease (IHD) and to the possibilities of antidepre...

    Full description

    Get full text
    Article
  13. 13

    Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer by O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova

    Published 2021-10-01

    Objective: to evaluate the clinical and economic feasibility of opioid therapy based on the analysis of its cost and effectiveness in patients with chronic pain syndrome in pancreatic cancer.Material and methods. An observational prospective study in parallel groups of patients with chronic pain syn...

    Full description

    Get full text
    Article
  14. 14

    Pharmacological predictors of heart rate and conductivity disorders in juvenile myoclonic epilepsy by N. A. Shnayder, M. M. Petrova, K. V. Petrov, R. F. Nasyrova

    Published 2021-07-01

    Juvenile myoclonic epilepsy (JME) is the most common form of genetic generalized epilepsy. Patients with JME are at risk of life-threatening heart rhythm and conduction disorders as well as sudden death syndrome due to several potential mechanisms: genetic, clinical, neuroanatomical, pharmacological...

    Full description

    Get full text
    Article
  15. 15

    Clinic and treatment of bronchial asthma, combined with cardiovascularpathology by N. V. Gordeyeva, I. V. Demko, M. M. Petrova, I. P. Artyukhov

    Published 2007-06-01

    The purpose of research - to study cardiovascular diseases frequency in patients with bronchial asthma (BA), the influence of cardiovascular disease on clinical course and severity of BA, the role of base and symptomatic therapy, to evaluate quality of diagnostics and treatment of cardiovascular dis...

    Full description

    Get full text
    Article
  16. 16

    Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome by I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova

    Published 2016-11-01

    Aim. To study the features of the state of hemostasis and platelet enzymes activity in acetylsalicylic acid (ASA) sensitive and resistant patients with acute coronary syndrome (ACS).Material and methods. The study included 53 patients (25 men and 28 women) with ACS during the first 24 hours and afte...

    Full description

    Get full text
    Article
  17. 17

    Antipsychotic-Induced QT Prolongation and Torsade de Pointes in Patients with Mental Disorders: A Review by R. F. Nasyrova, A. V. Kidyaeva, M. M. Petrova, N. A. Shnayder

    Published 2024-12-01

    INTRODUCTION. The high risk of life-threatening ventricular arrhythmias, particularly Torsade de Pointes (TdP), makes QT prolongation one of the most significant adverse drug reactions (ADRs) due to cardiotoxicity associated with antipsychotics (APs).AIM. This study aimed to systematise information...

    Full description

    Get full text
    Article
  18. 18

    Epidemiology of chronic inflammatory demyelinating polyneuropathy abroad and in Russia by T. E. Popova, N. A. Shnayder, M. M. Petrova, T. Ya. Nikolaeva, E. A. Kantimirova

    Published 2015-06-01

    Current article provides an overview of the results of epidemiological studies of chronic inflammatory demyelinating polyneuropathy (CIDP) in Russia and abroad. It is shown that the prevalence of CIDP is different in countries, due to the use of different diagnostic criteria. It should be noted that...

    Full description

    Get full text
    Article
  19. 19

    COGNITIVE DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE by O. V. Yeremina, M. M. Petrova, S. V. Prokopenko, N. V. Isaeva, D. S. Kaskaeva

    Published 2014-12-01

    Coronary artery bypass graft surgery (CABG) is one of the most effective methods of surgical treatment of ischemic heart disease (IHD). However, even improvement of life quality is evident in patients underwent CABG, some neuropsychological, cognitive alterations may appear. Therefore, the problem o...

    Full description

    Get full text
    Article
  20. 20

    Oxidative Distress in Pathogenesis of Alcoholic Liver and Its Correction by S. P. Smolina, M. M. Petrova, V. I. Sharobaro, S. V. Nikolaev, I. G. Bobrinskaya

    Published 2016-02-01

    The aim of the study was to evaluate the effect of the succinatecontaining antioxidants Reamberin and Cytoflavin on (1) free radical oxidation of lipids and functioning of the antioxidant system in patient with alcoholic liver disease and hepatic encephalopathy and (2) severity of hepatocellular dys...

    Full description

    Get full text
    Article